Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In September: Earnings Summary

TRACON Pharmaceuticals

14/11/2022 22:49

* TRACON Pharmaceuticals Inc  TCON.OQ  reported a quarterly
adjusted loss of 30 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * TRACON Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 30 cents​.
    * The mean earnings estimate of analysts had risen by
about 7.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * TRACON Pharmaceuticals Inc shares had fallen by 7.2% this
quarter and lost 44.0% so far this year.
    * The company reported a quarterly loss of $6.44 million.
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:48 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.28          -0.30          Missed
 Jun. 30 2022      -0.37          -0.31          Beat
 Mar. 31 2022      -0.42          -0.48          Missed
 Dec. 31 2021      -0.35          -0.40          Missed